Daniel F. Becker, MD


Primary Care Nurse Practitioner Management of Adolescent Behavioral Health

Personnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).

Fei Tang, PhD


Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.

Henry Sullivant, MD


A Novel Approach to Attribute Responsible Physicians Using Inpatient Claims

The authors propose a novel approach in which physicians’ responsibility for inpatient stays is expressed through physician-specific attribution ratios informed by patient characteristics.

Dennis Fried, PhD, MBA


Ambulatory Care Fragmentation and Hospitalization Among Veterans With Diabetes

Having highly fragmented ambulatory care and a usual provider of care outside the Veterans Health Administration increased the odds of hospitalization among veterans with diabetes.

Clarissa J. Diamantidis, MD, MHS


Have Racial Disparities in Home Dialysis Utilization Changed Over Time?

Medicare prospective payment for dialysis modestly increased availability and use of home-based dialysis treatment but did not affect historic racial disparities in home dialysis.

Susan R. Kirsh, MD, MPH


Cost Savings Associated With Electronic Specialty Consultations

This retrospective cohort evaluation found that patients receiving electronic, compared with face-to-face, specialty consultation had significantly lower health care costs for at least 3 months.

Jeffrey Botbyl, MS


Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.

Andrew W. Roberts, PharmD, PhD


Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs

High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.

Keith A. Horvath, MD


Trends in Sepsis and Pneumonia During COVID-19: Lessons From BPCIA

The authors analyzed cost and utilization changes for sepsis and pneumonia non–COVID-19 episodes prior to and during the pandemic, and during the pandemic for patients with and without COVID-19.

Michael R. Richards, MD, PhD, MPH


Removing Medicare’s Outpatient Ban and Medicare and Private Surgical Trends

This article documents a 100% increase in privately insured outpatient knee replacement surgeries following Medicare’s decision to remove knee replacements from its Inpatient Only list.

Blair Burnett, BA


Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.

Joyce Wang


Contributor: Providers and Patients Push Back, Payers Push Forward—Co-pay Mitigation Programs

Research shows how commercial health plans impact payer trends in the co-pay landscape and provides key areas that pharmaceutical and biotech manufacturers can explore to ensure patient access.

Sourya Sourabh Mohakuda, MD


Clinical Profile of COVID-19 Infection in Postvaccination Individuals

This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.

Jean L. Raphael, MD


TCD Screening and Spending Among Children With Sickle Cell Anemia

A substantial proportion of families of privately insured children with sickle cell anemia pay more than $100 for essential stroke screenings, a high-value service.

Scott A. Soefje, PharmD


Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.

Mark Stephens, MD


Mobile Health Clinic: Lessons Learned Building Partnerships Across Health Systems

Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.

Vannessa Harrison, DrPH


Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.

Edward Juhn, MD, MBA, MPH


Incentivizing Data Sharing Among Health Plans, Hospitals, and Providers to Improve Quality

Health plans can gain efficiencies and improve quality by connecting to health information networks and incentivizing hospital and provider participation as part of pay-for-performance programs.

Stella K. Kang, MD, MSc


When Does Nonadherence Indicate a Deviation From Patient-Centered Care?

The authors suggest that assessment of patient-centered care may be improved by flagging probable discordance between a patient’s preferences and their treatment care plan.

Gregory B. Russell, MS


Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease

Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.

Jacob E. Kurlander, MD, MS


Interest in and Concerns About Telehealth Among Adults Aged 50 to 80 Years

In this survey of adults aged 50 to 80 years, sociodemographic factors, as well as experience with video chat, were associated with interest in and concerns about telehealth video visits.

Chiao-Li Chan, MSW


Evaluating Alternative Methods of Comparing Antihypertensive Treatment Intensity

Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension management.

Dolly Sharma, PhD


Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

© 2023 MJH Life Sciences
All rights reserved.